Effects Of Ziltivekimab Versus Placebo On Morbidity And Mortality In Patients With Heart Failure With Mildly Reduced Or Preserved Ejection Fraction And Systemic Inflammation
Mark Petrie1; Barry Borlaug2; Kristine Buchholtz3; Anique Ducharme4; Anders Hvelplund3; Carolyn Lam Su Ping5; Guiomar Mendieta6; Søren Østergaard Hardt-Lindberg3; Adriaan Avoors7; Paul M Ridker8
Slide
Poster
Sunday, 08 October 2023
09:00 - 10:30
EDT
ORAL PRESENTATION
Effects Of Semaglutide Across The Range Of Left Ventricular Ejection Fraction In Obesity Phenotype Of Heart Failure With Preserved Ejection Fraction: The STEP-HFpEF Trial
Javed Butler1; Sanjiv J Shah2; Steen Z Abildstrøm2; Rebecca Lynn Altschul3; Barry A Borlaug4; Melanie J Davies5; G Kees Hovingh3; Dalane W Kitzman6; Daniél Vega Møller7; Mark C Petrie8; Søren Rasmussen7; Subodh Verma9; Mikhail N Kosiborod10
Slide
12:15 - 12:45
EDT
390
POSTER
Prevalence and Clinical Significance of Systemic Inflammation in HFpEF and HFmrEF
Barry A Borlaug1; Cecilie Holse2; Mette Holme Jung2; A Michael Lincoff3; Sharon L Mulvagh4; Jacob Stærk-Østergaard2; Katherine R Tuttle5; Mark C Petrie6